| 000 | 01175 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250515093235.0 | ||
| 264 | 0 | _c20080204 | |
| 008 | 200802s 0 0 eng d | ||
| 022 | _a1097-6825 | ||
| 024 | 7 |
_a10.1016/j.jaci.2007.09.027 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrishnan, Jerry A | |
| 245 | 0 | 0 |
_aOmalizumab for severe allergic asthma: dollars and sense. _h[electronic resource] |
| 260 |
_bThe Journal of allergy and clinical immunology _cNov 2007 |
||
| 300 |
_a1015-7 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aAnti-Asthmatic Agents _xeconomics |
| 650 | 0 | 4 | _aAntibodies, Anti-Idiotypic |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xeconomics |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aOmalizumab |
| 650 | 0 | 4 |
_aRespiratory Hypersensitivity _xdrug therapy |
| 700 | 1 | _aGould, Michael | |
| 773 | 0 |
_tThe Journal of allergy and clinical immunology _gvol. 120 _gno. 5 _gp. 1015-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jaci.2007.09.027 _zAvailable from publisher's website |
| 999 |
_c17501869 _d17501869 |
||